MRNA-1045 is under clinical development by Moderna and currently in Phase I for Respiratory Syncytial Virus (RSV) Infections. According to GlobalData, Phase I drugs for Respiratory Syncytial Virus ...
Utilizamos cookies para darte la mejor experiencia de usuario y entrega de publicidad, entre otras cosas. Si continúas navegando el sitio, das tu consentimiento para utilizar dicha tecnología ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback